No state requires universal drug testing of every baby born within its borders. Instead, each state sets its own rules about when and how hospitals can test newborns for prenatal drug exposure, and those rules range from mandatory testing when certain risk factors are present to leaving the decision entirely up to hospital policy. The differences between states are significant, affecting whether parental consent is needed, what triggers a test, and what happens when a result comes back positive.
How Testing Decisions Actually Work
Newborn drug testing in the United States falls into two broad categories: risk-based screening and universal screening. Most states follow a risk-based approach, meaning a baby is only tested when specific clinical signs or maternal history raise concern. A smaller number of hospitals have adopted universal screening policies on their own, testing every newborn regardless of risk factors, but this is a hospital-level decision rather than a state mandate.
Risk-based testing is triggered by things like a mother’s self-reported substance use, lack of prenatal care, signs of withdrawal in the newborn (tremors, high-pitched crying, seizures, poor feeding), or a prior history with child protective services. The problem with risk-based screening is that it introduces bias. Studies have repeatedly shown that Black and lower-income women are tested at higher rates than white women with similar substance use patterns, even when clinical indicators are comparable.
States That Require Testing Under Certain Conditions
Several states have laws that specifically authorize or require newborn drug testing when a healthcare provider suspects prenatal substance exposure. These are not blanket mandates for all births but legal frameworks that compel testing once suspicion exists.
- Louisiana: If a physician believes a newborn was exposed in utero to an unlawfully used controlled substance, the physician must order a toxicology test on the newborn without the consent of the parents or guardian.
- Minnesota: Physicians caring for a newborn must perform toxicology tests if they have reason to believe, based on a medical assessment of the mother or infant, that the mother used a controlled substance for a nonmedical purpose during pregnancy. Some hospitals in Minnesota test women without consent.
- South Dakota: Healthcare practitioners may administer a toxicology test to a newborn, with or without parental consent, if they have reason to believe the mother used a controlled substance for a nonmedical purpose during pregnancy.
Other states leave the decision to individual hospitals and physicians, with no statute specifically addressing newborn drug testing. In those states, hospital protocols vary widely. Two hospitals in the same city may have completely different testing thresholds.
What Happens When a Test Is Positive
Every state requires healthcare providers to report suspected child abuse or neglect, and in most states, a positive newborn drug test triggers a mandatory report to child protective services. But the federal law that governs this, the Child Abuse Prevention and Treatment Act (CAPTA), requires states to have policies for “substance-affected” newborns without specifying exactly what that means. The federal language is deliberately vague, though it must cover infants with fetal alcohol spectrum disorder, withdrawal symptoms, or both.
A positive test does not automatically mean a child is removed from the home or that a parent faces criminal charges. In New York, for example, the state’s child abuse registry will not register a report if the parent is compliant with a drug treatment program, is using prescribed medication under a doctor’s supervision, and is demonstrating the ability to care for the infant. A positive result for cannabis or alcohol alone, without a demonstrated effect on the baby, is also not sufficient to register a report in New York. The state explicitly recognizes that a positive toxicology result, by itself, does not prove abuse or maltreatment.
Other states take a harder line. The consequences of a positive test can range from a referral to social services and a “plan of safe care” (a support plan for the family) to a full child protective investigation and, in rare cases, criminal prosecution.
States Where Criminal Charges Are Possible
A handful of states have interpreted existing laws or passed new ones that can turn prenatal drug use into a criminal offense. This is where the stakes become most severe.
Alabama’s Supreme Court ruled in 2013 and 2014 that prosecutors can charge a woman who uses drugs during pregnancy with chemical endangerment of a child. South Carolina’s Supreme Court held in 1997 that a fetus is a person and that maternal acts endangering a viable fetus constitute child abuse. Tennessee is the only state that passed a statute specifically making it a crime to use drugs while pregnant, though that law has expired and been the subject of ongoing debate. In Florida and Oklahoma, women have been charged with child abuse and criminal child neglect, respectively, based on drug use during pregnancy.
These prosecutions remain controversial. Medical organizations including the American College of Obstetricians and Gynecologists have argued that criminalizing prenatal drug use discourages women from seeking prenatal care and substance abuse treatment, ultimately harming both mother and child.
Consent and Testing Without Your Knowledge
Whether a hospital needs your permission to test your baby depends on where you deliver. In states like Louisiana and South Dakota, the law explicitly allows testing without parental consent when suspicion exists. In many other states, the law is silent on consent, and hospitals set their own policies. Some require verbal or written consent before running a toxicology screen. Others include drug panels as part of routine bloodwork without separate notification.
There is growing pushback against nonconsensual testing. In New York, a 2025 bill called the Maternal Health, Dignity and Consent Act would prohibit drug, cannabis, or alcohol testing of both newborns and pregnant or postpartum individuals unless the individual gives prior written and oral informed consent specific to that test, and the test falls within the scope of medical care being provided. If passed, it would be one of the strongest consent protections in the country.
How Newborn Drug Tests Work
Hospitals use three main specimen types to detect prenatal drug exposure, each with a different detection window.
Urine is the simplest to collect but has the shortest detection window, generally reflecting exposure only in the final days before birth. Meconium, the baby’s first stool, is considered the gold standard for neonatal drug testing. It begins forming during the second trimester, so it can capture drug exposure over roughly the last 20 weeks of pregnancy. The drawback is timing: meconium may take several days after birth to pass, delaying results.
Umbilical cord tissue has become increasingly popular because it’s available immediately at birth. Research published in the Journal of Analytical Toxicology found that umbilical cord testing actually produced higher positivity rates than meconium (56.6% vs. 52.4% in paired specimens), largely because labs use much lower detection thresholds for cord tissue, roughly four times lower on average. However, meconium contains higher actual concentrations of drugs. The cord’s composition changes over time and is more likely to pick up substances given during labor and delivery, like morphine for pain management, which may not reflect the mother’s drug use during pregnancy.
False Positives Are a Real Concern
Initial screening tests use a method called immunoassay, which casts a wide net but is prone to cross-reactivity. Amphetamines and benzodiazepines have particularly high false-positive rates. Certain prescription medications, over-the-counter cold remedies, and even poppy seed consumption can trigger a positive opiate result, though confirmation testing can usually distinguish dietary exposure from actual drug use based on concentration levels.
Any positive screening result should be confirmed with a more precise method like gas chromatography-mass spectrometry, which identifies specific compounds rather than drug classes. If you’re told your baby tested positive on an initial screen, confirmation testing is the critical next step, and the result of that confirmation test is what matters for any legal or child welfare proceedings.
What Triggers Testing in Practice
Even in states without specific testing laws, hospitals commonly test newborns who show signs of neonatal abstinence syndrome. The symptoms providers watch for include tremors, irritability, increased muscle tone, high-pitched crying, excessive yawning and sneezing, fever, poor feeding, vomiting, and diarrhea. Hospitals use standardized scoring tools to rate these symptoms, and scores above certain thresholds may prompt both testing and treatment.
These same symptoms can also be caused by low blood sugar, infections, thyroid problems, or even maternal use of antidepressants (SSRIs) and tobacco during pregnancy. A baby showing signs of withdrawal does not automatically mean illegal drug exposure, which is another reason confirmation testing and careful medical evaluation matter before any conclusions are drawn.